Huawei Technologies Co., Limited

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Chengdu Kanghong Biotechnologies Co., Ltd.

Nanjing University of Chinese Medicine

Zheng Liu

Jianmin Fang

Xiquan Zhang

Zhongmin Maxwell Wang

Xin Tian

Rong Li

Wei Li

Xiangjian Wang

Chen Shen

Xiaoping Jin

Peng Lyu

Tianqing Chu

Baohui Han

Hua Zhong

Dechao Yu

Hongmei Wen

Huimin Bian

Long Chen

The present application provides a therapeutic combination of a quinoline derivative and an antibody, which comprises an immune checkpoint inhibitor and a tyrosine kinase inhibitor, wherein the tyrosine kinase inhibitor is a compound of formula I or a pharmaceutically acceptable salt thereof. The therapeutic combination in the present application shows good activity against lung tumor and liver tumor.

Therapeutic combination of quinoline derivative and antibody

Embodiments of the present invention provide a method and terminal for operating through a touch screen. The method includes: after a transparent virtual keyboard is displayed, receiving a first operation for a display area of the transparent virtual keyboard through a touch screen; determining, according to the first operation, that a target object of the first operation is a page content in the display area of the transparent virtual keyboard; and performing the first operation for the page content in the display area of the transparent virtual keyboard. Therefore, the operation may be directly performed for the determined target object. Therefore, no additional operation is required to perform switching between the transparent virtual keyboard and the page, thereby reducing user operations and improving the user experience.

Method and terminal for determining operation object

An application of 2,5-dihydroxymethyl-3,6-dimethyl pyrazine and its derivatives in the preparation of drugs for the treatment of, prevention of, and/or protection from heart failure wherein the structural formula of the compound is as follows: 

Application of 2,5 -dihydroxymethyl-3,6-dimethyl pyrazine and its derivates in pharmacy

The present invention is directed to DNA sequence encoding angiogenesis-inhibiting recombinant chimeric protein, the chimeric protein per se, the pharmaceutical use of the chimeric protein, and to the pharmaceutical composition containing the recombinant protein and the formulation thereof.

Angiogenesis-inhibiting chimeric protein and the use

Growing community of inventors

Nanjing, China

Zheng Liu